大学院医学研究院

研究分野

ライフサイエンス / 心臓血管外科学 /
ライフサイエンス / 呼吸器外科学 /

経歴

12 >

2023年4月

-

現在

国際医療福祉大学成田病院病院長

2023年4月

-

現在

千葉大学医学部附属病院特任教授

2007年

-

2023年3月

千葉大学大学院医学研究院教授

2004年

-

2007年

九州大学大学院医学研究院准教授

2003年

-

2004年

九州大学附属病院講師

学歴

1992年8月

-

1994年6月

ハーバード大学ブリガムアンドウーメンズ病院外科

1992年8月

-

1994年6月

Harvard Medical School, Brigham and Women's Hospital

-

1992年

九州大学医学研究科外科学

-

1992年

九州大学医学研究科外科学

-

1987年

九州大学医学部医学科

委員歴

12 >

2002年

American College of Surgeons Fellow

2002年

Japan Lung Cancer Society Member of Comittee

2002年

日本肺癌学会評議員

2002年

米国外科学会正会員

2001年

Japanese Association for Chest Surgery Member of Comittee

論文

12 3 4 5 >

What are the risk factors for postoperative home oxygen therapy in patients with lung cancer?

Takahiro Yamanaka Yuichi Sakairi Yuki Sata Takahide Toyoda Terunaga Inage Kazuhisa Tanaka Hidemi Suzuki Yukiko Matsui Ichiro Yoshino

Journal of thoracic disease 16(2) 989-996 2024年2月

BACKGROUND: Home oxygen therapy (HOT) is used to treat chronic respiratory diseases and is sometimes required in patients with lung cancer after radical surgery. We aimed to identify the risk factors for postoperative home-based oxygen therapy in ...

Efficacy of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Non-Small Cell Lung Cancer Patients with Poor Performance Status and Epidermal Growth Factor Receptor Mutations: Findings from the Japanese Lung Cancer Registry Database.

Yusuke Okuma Yasushi Shintani Ikuo Sekine Takehito Shukuya Koichi Takayama Akira Inoue Isamu Okamoto Katsuyuki Kiura Nobuyuki Yamamoto Tomoya Kawaguchi Etsuo Miyaoka Ichiro Yoshino Hiroshi Date

Clinical lung cancer 2024年2月

BACKGROUND: In advanced non-small cell lung cancer (NSCLC) patients harboring epidermal growth factor receptor (EGFR) mutations, those with impaired performance status (PS) treated with EGFR-tyrosine kinase inhibitors (TKIs) have demonstrated comp...

Long-term nintedanib treatment for progressive pulmonary fibrosis associated with Hermansky-Pudlak syndrome type 1 followed by lung transplantation.

Taku Itoh Takeshi Kawasaki Taisuke Kaiho Kohei Shikano Akira Naito Mitsuhiro Abe Hidemi Suzuki Masayuki Ota Ichiro Yoshino Takuji Suzuki

Respiratory investigation 62(1) 176-178 2023年12月

Hermansky-Pudlak syndrome (HPS) is a rare autosomal recessive disease that often causes progressive pulmonary fibrosis (HPS-PPF) in some genetic types with high mortality rates. No effective treatment for HPS-PPF other than lung transplantation ha...

Outcomes of carbon ion radiotherapy compared with segmentectomy for ground glass opacity-dominant early-stage lung cancer.

Teruaki Mizobuchi Akihiro Nomoto Hironobu Wada Naoyoshi Yamamoto Mio Nakajima Takehiko Fujisawa Hidemi Suzuki Ichiro Yoshino

Radiation oncology (London, England) 18(1) 201-201 2023年12月

PURPOSE: This study aimed to compare the outcomes of patients with ground-grass opacity (GGO)-dominant non-small cell lung cancer (NSCLC) who were treated with carbon ion radiotherapy (CIRT) versus segmentectomy. METHODS: A retrospective review of...

Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan.

Seiki Hasegawa Yasushi Shintani Teruhisa Takuwa Keisuke Aoe Katsuya Kato Nobukazu Fujimoto Yasuhiro Hida Masahiro Morise Yasumitsu Moriya Takao Morohoshi Hidemi Suzuki Masayuki Chida Shunsuke Endo Mitsutaka Kadokura Meinoshin Okumura Satoshi Hattori Hiroshi Date Ichiro Yoshino

Cancer science 2023年12月

Due to the scarcity of large-sized prospective databases, the Japanese Joint Committee for Lung Cancer Registry conducted a nationwide prospective registry for newly diagnosed and untreated pleural mesothelioma. All new cases diagnosed pathologica...